Millions of people take statins every day, trusting they’re protecting their heart. And they might be—but probably not as much as they think.
Statins lower LDL cholesterol and can reduce your risk of heart attacks and strokes. That’s real. But here’s what often gets lost in the conversation: the benefits are surprisingly modest for most people, and the tradeoffs deserve more attention than they typically receive.
Who Actually Benefits?
Not everyone gains equally from statins, and the numbers tell a striking story.
If you’ve already had a heart attack or stroke (what doctors call “secondary prevention”), statins offer the clearest benefit. Even so, about 30 to 40 people need to take the medication for five years to prevent one major cardiovascular event. That means most people taking it won’t personally experience that benefit—but someone in the group will.
If you haven’t had a cardiovascular event (primary prevention), the picture shifts dramatically. Here, the number needed to treat often exceeds 100, sometimes climbing past 200. Translation: many people take statins for years, even decades, without ever seeing a meaningful health outcome from it.
How Much Life Do Statins Actually Add?
For people without existing heart disease, research suggests statins may extend life by an average of days to weeks—not years. That’s a far cry from what many patients imagine when they fill their prescription.
Meanwhile, side effects are more common than often acknowledged. Muscle pain, persistent fatigue, brain fog, rising blood sugar, and reduced energy (partly due to depleted CoQ10 levels) affect a meaningful portion of users. For some, these effects are mild. For others, they’re life-altering.
Cholesterol Isn’t the Villain It’s Made Out to Be
We’ve been conditioned to fear cholesterol, but your body needs it to survive and thrive.
Cholesterol is the raw material for crucial hormones: estrogen, progesterone, testosterone, and cortisol. It’s essential for producing vitamin D, creating bile acids that help you digest food, supporting brain function, and maintaining healthy cell membranes throughout your body.
When you aggressively lower cholesterol—especially without considering the bigger hormonal picture—you may inadvertently worsen fatigue, mood instability, and your ability to handle stress. This is particularly concerning for perimenopausal and menopausal women, whose hormonal systems are already in flux.
The Moving Target of “High” Cholesterol
Here’s something worth questioning: the threshold for “high” cholesterol has steadily dropped over the decades, placing more and more people on statins—even those at relatively low risk.
It’s also worth noting that Lipitor, the most famous statin, became the most profitable drug in pharmaceutical history. That doesn’t make statins inherently bad, but it does underscore why your treatment decisions should be thoughtful, individualized, and genuinely in your best interest.
A Bigger Picture Approach
Statins may have a role for certain people, but heart health is far more complex than a single cholesterol number.
A truly comprehensive approach considers:
- Your actual cardiovascular risk based on multiple factors, not just LDL
- Insulin resistance and chronic inflammation
- Thyroid function and liver health
- Hormonal balance across the board
- Lifestyle foundations: sleep quality, nutrition, movement, and stress management
For many people, addressing root causes can support cardiovascular health powerfully—sometimes without medication, sometimes alongside it, but always with more context and care.
What You Can Do
If you’re currently taking a statin—or your doctor has suggested starting one—you deserve a deeper conversation.
Schedule a consultation to review your complete picture: your labs, your lifestyle, your risk factors, and your health goals. Together, we can create a personalized plan that genuinely protects your heart while also supporting your energy, hormones, and overall vitality.
Because lowering cholesterol is easy. Optimizing health? That takes more—and you’re worth it.
References:
Collins, R., et al. (2013). Statin therapy for primary prevention of cardiovascular disease. The Cochrane Database of Systematic Reviews. https://www.ncbi.nlm.nih.gov/books/NBK598478/ (statin efficacy and NNT)
Jong, J. C., et al. (1995). Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. PubMed. https://pubmed.ncbi.nlm.nih.gov/14692706/ (benefit in primary vs secondary prevention) National Institute for Health and Care Excellence. (2014). Cardiovascular disease: Risk assessment and reduction, including lipid modification. https://gpevidence.phc.ox.ac.uk/conditions/lipids/ (example NNT estimates)
Shepherd, J., et al. (1995). West of Scotland Coronary Prevention Study (WOSCOPS). New England Journal of Medicine. https://en.wikipedia.org/wiki/West_of_Scotland_Coronary_Prevention_Study (a landmark primary prevention trial)
Wikipedia. (n.d.). Atorvastatin. https://en.wikipedia.org/wiki/Atorvastatin (Lipitor history and sales figures)
Miller, W. L. (2015). Steroid hormone synthesis in mitochondria. Molecular and Cellular Endocrinology, 408, 1–10. (cholesterol role in hormone production)